Breaking News Bar
posted: 7/10/2011 12:01 AM

Take action against pancreatic cancer

hello
Success - Article sent! close
 

In June, over 500 advocates from around the country traveled to Washington, D.C., to meet with their legislators and thousands of others called in as part of Pancreatic Cancer Advocacy Day. Our message was simple: We will not wait any longer for action against pancreatic cancer. We must pass the Pancreatic Cancer Research & Education Act (S 362/HR 733) now!

I just lost my father to pancreatic cancer less than four weeks after his diagnosis. My father was only 64 years old and I expected him to live until he was 100. My family and I miss him terribly and do not want any other families to have to go through the pain we did.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

It's been 40 years since Congress passed the National Cancer Act, and despite considerable improvement in overall cancer survival rates, pancreatic cancer still has a survival rate of just 6 percent and still no early detection tools or effective treatments. Even more alarming, the number of patients diagnosed with this disease is expected to increase by 55 percent in the next 20 years. In spite of these statistics, the National Cancer Institute allocates only about 2 percent of its $5 billion research budget for pancreatic cancer.

The best way to fight this disease and change the status quo is to pass the Pancreatic Cancer Research & Education Act. I call on our entire delegation to Congress to co-sponsor this critical legislation now so that we can begin to reverse the direction of pancreatic cancer and offer newly diagnosed patients real hope.

Elizabeth Hornback

Montgomery

Share this page